ATNM Actinium Pharmaceuticals Forecast, Technical & Fundamental Analysis
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells... Show more
ATNM is expected to report earnings to fall 5.78% to -21 cents per share on August 03
Q2'26
Est.
$-0.22
Q1'26
Missed
by $0.01
Q4'25
Missed
by $0.01
Q3'25
Beat
by $0.16
Q2'25
Beat
by $0.13
The last earnings report on May 11 showed earnings per share of -23 cents, missing the estimate of -21 cents. With 75.89K shares outstanding, the current market capitalization sits at 29.18M.
A.I. Advisor
published General Information
General Information
a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers
A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with MRNA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then MRNA could also see price increases.
ATNM's Stochastic Oscillator descending into oversold zone
The Stochastic Oscillator for ATNM moved into oversold territory on July 10, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ATNM's RSI Oscillator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on July 10, 2026. You may want to consider a long position or call options on ATNM as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ATNM just turned positive on June 30, 2026. Looking at past instances where ATNM's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATNM advanced for three days, in of 231 cases, the price rose further within the following month. The odds of a continued upward trend are .
ATNM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
ATNM moved below its 50-day moving average on June 03, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATNM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for ATNM entered a downward trend on July 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.658) is normal, around the industry mean (22.889). P/E Ratio (0.000) is within average values for comparable stocks, (37.790). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.508). ATNM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (322.581) is also within normal values, averaging (434.236).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ATNM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATNM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
